New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
09:31 EDTNWBONorthwest Biotherapeutics price target raised to $15.10 at Summer Street
Summer Street raised its price target for Northwest Biotherapeutics shares to $15.10 from $10.33 after the company announced that Germany has approved its glioblastoma multiforme vaccine for an early access program. The firm views the news as a "very strong endorsement" from the German government and reiterates a Buy rating on Northwest.
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
15:23 EDTNWBONorthwest Biotherapeutics announces $35M in financing actions
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use